Lung cancer, one of the most common and deadly types of cancer globally, continues to be a significant public health issue. Non-small cell lung cancer (NSCLC) represents the majority of lung cancer cases, accounting for approximately 85% of all lung cancers. However, with the rapid advances in cancer research and personalized medicine, novel targeted therapies are emerging to improve the...